[Email to David Baltimore from Bruce Weniger with Draft of PACHA Recommendations]

is taking longer than it should. Current Issues in Public
Health, 1, 181-185.
Green, J. (1995). Who put the lid on gpl20? The New
York Times Magazine, March 26, 50-57, 74, 82.
Heyward, W. L. MacQueen, K. M., & Jaffe, H. W. (1997).
Obstacles and progress toward development of a
preventive HIV vaccine. Journal of the International
Association of Physicians in AIDS Care, 3, 28-34.
Mahoney, R. T. (1996). Developing vaccines against
HIV: Options for accelerated progress. AIDS & Public
Policy Journal, 11, 28-35.
Mascola, J. R., McNeil, J. G., Burke, D. S. (1994).
AIDS vaccines: Are we ready for human efficacy trials?
JAMA, 272, 488-489.
NIH, NIAID, HIV Vaccine Working Group. Transcript of
minutes - April 21-22, 1994. (www.hsph.harvard.edu/
organizations/hailvaccines/preamble. html).
NIH, NIAID, Division of AIDS,. Joint meeting of the AIDS
Subcommittee of the National Advisory Allergy and
Infectious Diseases Council and the AIDS Research
Advisory Committee. Transcript of minutes from June
17, 1994. (www.hsph.harvard.edulorganizations/hail
vaccines/preamble, html).
NIH, NIAID AIDS Agenda. (1997). New phase II HIV
vaccine study opens. August, 3.
The Rockefeller Foundation. (1994). HIV vaccines -
accelerating the development of preventive HIV vaccines
for the world. Summary report and recommendations of
an international meeting. Bellagio, Italy, March 7-11, 1-27.
The Rockefeller Foundation. (1994). HIV vaccines -
accelerating the development of preventive HIV vaccines
for the world. Summary report and recommendations of
an international ad hoc scientific committee. Paris, France,
October 27-28, 1-24.
The Rockefeller Foundation. (1995). The international
AIDS vaccine initiative. Financial and structural issues.
Summary report and recommendations of an international
meeting. New York, August 17, 1-16.
Russell, P. K. (1995). Heading off a crisis in vaccine
development. Issues in Science and Technology, 11, 26-32.'
Russell, P. K. (1997). Economic obstacles to the optimal
utilization of an AIDS vaccine. Journal of the International
Association of Physicians in AIDS Care, 3(9), 31-33.
Rutter, W. (1997). HIV vaccine development necessary
for humanity. SidAlerte Quarterly TB & HIV, 14, 13-14.
Schoofs, M. (1995). We could have an AIDS vaccine: So
why don't we? The Village Voice, September 12, 20-24.

Shepherd, H. R. (1996). Still needed: An AIDS vaccine.
The Wall Street Journal, December 3, A22.
UNAIDS, Vaccine Advisory Committee (VAC). (1997).
Conclusions and recommendations of the first meeting of
the "vaccine advisory committee (VAC)". Geneva,
April 23-25, 1-6.
Weniger, B.G., & Essex, M. (1997). Clearing the way for an